antifungal Archives -

Mundipharma and Cidara Therapeutics have reported the results of a phase 3 trial of their new once-weekly antifungal

Cidara and Mundipharma prep filings for antifungal rezafungin

https://pharmaphorum.com/news/cidara-and-mundipharma-prep-filings-for-antifungal-rezafungin/

Scynexis has filed for FDA approval of its novel drug ibrexafungerp which – if approved – would be

Scynexis bids to end novel antifungal drought, filing ibrexafungerp in US

https://pharmaphorum.com/news/scynexis-bids-to-end-novel-antifungal-drought/

Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening

Novo-backed $61m fundraising helps F2G prep for antifungal launch

https://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/

Exclusive Interview with Martin Everett

Exclusive Interview with Martin Everett, CSO, Antabio, speaking at Superbugs & Superdrugs

https://pharmaphorum.com/partner-content/exclusive-interview-with-martin-everett-cso-antabio-speaking-at-superbugs-superdrugs/

US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug VL-2397,

Vical slashes staff after culling phase II antifungal

https://pharmaphorum.com/news/vical-staff-culling-phase-ii-antifungal/

antifungal